Caribou Biosciences
CRBU
151 hedge funds and large institutions have $343M invested in Caribou Biosciences in 2024 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 44 increasing their positions, 46 reducing their positions, and 20 closing their positions.
35% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 20
13% more call options, than puts
Call options by funds: $628K | Put options by funds: $555K
5% more funds holding
Funds holding: 144 → 151 (+7)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
4% less repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 46
4.22% less ownership
Funds ownership: 78.12% → 73.91% (-4.2%)
13% less capital invested
Capital invested by funds: $396M → $343M (-$52.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SSA
Schonfeld Strategic Advisors
New York
|
+$11.4M |
| 2 |
State Street
Boston,
Massachusetts
|
+$7.57M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$4.54M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$3.25M |
| 5 |
RAM
Readystate Asset Management
Chicago,
Illinois
|
+$2.12M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$13.8M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
-$5.57M |
| 3 |
Pictet Asset Management
Carouge,
Switzerland
|
-$5.39M |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$5.16M |
| 5 |
PBA
Paradigm Biocapital Advisors
New York
|
-$4.63M |
CRBU Hedge Fund Activity: Q1 2024 in Review
151 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Caribou Biosciences (CRBU) for Q1 2024, worth a combined $343M — down 13% from $396M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new CRBU positions and 20 closed out — a net gain of 7 holders — while 44 added to existing stakes and 46 trimmed.
The largest buyer was Schonfeld Strategic Advisors, opening a new position worth an estimated $11.4M. The largest seller was Assenagon Asset Management, cutting an estimated $13.8M.
- 151 institutional investors held Caribou Biosciences (CRBU) as of Q1 2024, up from 144 in Q4 2023.
- Funds reported $343M of Caribou Biosciences stock for Q1 2024, down 13% quarter-over-quarter.
- 27 funds opened new Caribou Biosciences positions in Q1 2024 and 20 closed out, a net change of +7 holders.
- The largest Caribou Biosciences buyer in Q1 2024 was Schonfeld Strategic Advisors, an estimated $11.4M added.
- The largest Caribou Biosciences seller in Q1 2024 was Assenagon Asset Management, an estimated $13.8M sold.
Based on aggregated 13F filings for Q1 2024.